The Bristol GDNF results

  Today – 27th February, 2019 – the long-awaited results of the Phase II GDNF clinical trial were published. GDNF (or glial cell line-derived neurotrophic factor) is a protein that our bodies naturally produce to nurture and support cells. Extensive preclinical research suggested that this protein was particularly supportive of dopamine neurons – a group […]


Exciting Exenatide Exosomes

  Recent analysis of blood samples collected during the Phase II clinical trial of Exenatide in Parkinson’s has uncovered a very interesting finding that could have major implications for not only Parkinson’s, but for many different neurological conditions. Exenatide is a treatment that helps to control glucose levels in people with diabetes. More recently, however, […]


Tom Isaacs award winners 2018 – Prof. Bas Bloem & Dr Simon Stott

Cure Parkinson’s and Van Andel Research Institute have announced Dr. Simon Stott (above left) and Professor Bastiaan Bloem (above right) as joint recipients of this year’s ‘Tom Isaacs Award’. The comprehensive nominations for both candidates made choosing between them very difficult – therefore it was…


Tom Isaacs Award winner 2017 – Prof. Tom Foltynie

Cure Parkinson’s and Van Andel Institute (VAI) are proud to announce Professor Tom Foltynie, Consultant Neurologist and Researcher at University College, London, as the inaugural winner of the Tom Isaacs Award. The award was presented today at the annual Grand Challenges in Parkinson’s conference and Rallying to the…


Our BBC Lifeline Appeal presented by Gavin Hastings

Former Scotland and British Lions captain Gavin Hastings presented the Cure Parkinson’s BBC Lifeline Appeal (a monthly charity appeal programme) which was broadcast on BBC One on Sunday 19th March 2017 and repeated on BBC Two Wednesday 22nd March. Gavin’s wife Diane was diagnosed with Parkinson’s in 2003 when their…